GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » EV-to-EBITDA

Radient Technologies (Radient Technologies) EV-to-EBITDA : -1.60 (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Radient Technologies's enterprise value is $9.86 Mil. Radient Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was $-6.15 Mil. Therefore, Radient Technologies's EV-to-EBITDA for today is -1.60.

The historical rank and industry rank for Radient Technologies's EV-to-EBITDA or its related term are showing as below:

RDDTF's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 14.42
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), Radient Technologies's stock price is $0.0001. Radient Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-0.015. Therefore, Radient Technologies's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Radient Technologies EV-to-EBITDA Historical Data

The historical data trend for Radient Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies EV-to-EBITDA Chart

Radient Technologies Annual Data
Trend Dec13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.32 -9.48 -1.85 -1.57 -4.61

Radient Technologies Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.24 -4.61 -3.65 -2.14 -2.04

Competitive Comparison of Radient Technologies's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Radient Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Radient Technologies's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Radient Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Radient Technologies's EV-to-EBITDA falls into.



Radient Technologies EV-to-EBITDA Calculation

Radient Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9.861/-6.147
=-1.60

Radient Technologies's current Enterprise Value is $9.86 Mil.
Radient Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Radient Technologies  (OTCPK:RDDTF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Radient Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0001/-0.015
=At Loss

Radient Technologies's share price for today is $0.0001.
Radient Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.015.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Radient Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Radient Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Radient Technologies (Radient Technologies) Business Description

Traded in Other Exchanges
N/A
Address
4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4
Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.